ZAMBELLI, ALBERTO

ZAMBELLI, ALBERTO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 207 (tempo di esecuzione: 0.016 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment Pathway 01 - Articolo su rivista 2025 Zambelli A. +
Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patients 01 - Articolo su rivista 2025 Zambelli A. +
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologists 01 - Articolo su rivista 2025 Zambelli A. +
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 01 - Articolo su rivista 2025 Zambelli A. +
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study 01 - Articolo su rivista 2025 Zambelli A. +
Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses 01 - Articolo su rivista 2025 Zambelli A. +
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates 01 - Articolo su rivista 2025 Merlo, FedericoSala, IsabellaPagan, EleonoraZambelli, AlbertoBagnardi, Vincenzo +
Bone-Active Drugs in Pre-Menopausal Women with Breast Cancer Under Hormone Deprivation Therapies 01 - Articolo su rivista 2024 Zambelli, A +
BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with Senonetwork 01 - Articolo su rivista 2024 Zambelli A. +
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer 01 - Articolo su rivista 2024 Zambelli, A +
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study 01 - Articolo su rivista 2024 Cazzaniga M. E.Zambelli A. +
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 01 - Articolo su rivista 2024 Zambelli A. +
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 01 - Articolo su rivista 2024 Zambelli, A +
Correction to: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors (Journal of Endocrinological Investigation, (2023), 47, 2, (433-442), 10.1007/s40618-023-02174-5) 99 - Altro 2024 Zambelli A. +
Corrigendum to “Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis” [Crit. Rev. Oncol./Hematol. 204 (2024) 104527](S1040842824002701)(10.1016/j.critrevonc.2024.104527) 99 - Altro 2024 Zambelli A. +
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions 01 - Articolo su rivista 2024 Zambelli, A +
Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations 01 - Articolo su rivista 2024 Zambelli A. +
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 01 - Articolo su rivista 2024 Zambelli, A +
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 01 - Articolo su rivista 2024 Zambelli A. +
Empowering beyond Pain: Pain Neuroscience Education Interventions in Breast Cancer Survivorship Care 01 - Articolo su rivista 2024 Zambelli A. +